Shenzhen Chenghui Medical Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shenzhen Chenghui Medical Technology Co., Ltd. - overview
Established
2022
Location
Shenzhen, Guangdong, China
Primary Industry
Medical Devices & Equipment
About
Based in Shenzhen, China and founded in 2022, Chenghui Medical is a company that develops, manufactures and distributes molecular diagnostic instruments and reagents. In February 2026, Shenzhen Chenghui Medical Technology Co. , Ltd. closed a round of series B+ funding from Dongguan Biotechnology Industry Development Fund.
Shenzhen Chenghui Medical Technology Co. , Ltd. primarily develops fully automated nucleic acid detection systems and related reagents based on microfluidics. The company's ultra-multiplexed molecular POCT (point-of-care testing) platform can fully automatically performs column extraction and eight-chamber QPCR (quantitative polymerase chain reaction) reactions within a fully enclosed centrifugal microfluidic chip.
The company's products are used in clinical diagnosis, epidemic prevention and control, and other fields. The company generates revenue from the research, development, production, and sales of its products and other related services. The company will use the series B+ funding to continue to innovate in the field of molecular diagnostic instruments and reagents research and development.
Current Investors
Guangdong Boji Venture Capital Management
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Medical Supplies
Verticals
HealthTech, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.